Evidence map›Paper›PMID 39810047›Full record

ReviewCurrent treatment options in oncology2025

A fishnet between nasopharyngeal carcinoma and resistance: the competing endogenous RNA network.

Mingtai Li, Tongtong Mo, Zisha Yang, Yunhong Yao, Yan Wang, Yi Zhao

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current treatment options in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mingtai Li *Second School of Clinical Medicine, Guangdong Medical University, Dongguan, 523808, Guangdong Province, China.
Tongtong Mo *Second School of Clinical Medicine, Guangdong Medical University, Dongguan, 523808, Guangdong Province, China.
Zisha Yang *Institute of Laboratory Medicine, School of Medical Technology, Guangdong Medical University, Dongguan, 523808, Guangdong, China.
Yunhong YaoPathology Department of The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523713, China.
Yan WangMicrobiology and Immunology Department, Guangdong Medical University, Dongguan, 523808, Guangdong, China. wangyan29@gdmu.edu.cn.
Yi ZhaoPathology Department of The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523713, China. zhaoyicomnet@163.com.

Funding

Graduate Education Innovation Program Project of Guangdong Province 2022SFKC063Graduate Education Innovation Program Project of Guangdong Province 2022XSLT047Natural Science Foundation of Guangdong Province 2015A030310046Natural Science Foundation of Guangdong Province 2016A030313674Research Foundation Project of Guangdong Medical University Z2015004Research Foundation Project of Guangdong Medical University Z2017005Science and Technology Planning Project of Guangdong Province 2016A020215224The National Natural Science Foundation of China 81572566
6 · The paper itself

Abstract

opinion statementChemotherapy and radiotherapy (chemo-/radiotherapy) have advanced as the main treatment modalities for nasopharyngeal carcinoma (NPC), improving patient survival rates. However, chemo-/radiotherapy resistance in NPC cells has emerged as a key factor contributing to poor prognosis. Recently, competing endogenous RNA networks (ceRNETs) have garnered attention for their potential clinical value in studying chemo-/radiotherapy resistance. In this review, we aimed to explore the molecular mechanisms of ceRNA-related molecules, including circular RNA (circRNA), long non-coding RNA (lncRNA), microRNA (miRNA), and other competing endogenous RNAs, in regulating the chemo-/radiotherapy resistance in NPC. Additionally, we discuss the potential applications of ceRNA as a prognostic indicator and therapeutic target for this resistance.

Indexed as

Drug Resistance, NeoplasmGene Regulatory NetworksNasopharyngeal CarcinomaNasopharyngeal NeoplasmsRadiation ToleranceBiomarkers, TumorGene Expression Regulation, NeoplasticHumansMicroRNAsPrognosisRNA, CircularRNA, Competitive EndogenousRNA, Long NoncodingBiomarkers, TumorMicroRNAsRNA, CircularRNA, Competitive EndogenousRNA, Long NoncodingChemo-/radiotherapy resistanceCompetitive endogenous RNACompetitive endogenous RNA networkNasopharyngeal carcinomaNcRNA

Identifiers

PMID39810047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.